Holroyd S, Currie L, Wooten G F
Department of Psychiatric Medicine, University of Virginia Health Sciences Center, Box 880623, Charlottesville, Virginia 22908, USA.
J Neurol Neurosurg Psychiatry. 2001 Jun;70(6):734-8. doi: 10.1136/jnnp.70.6.734.
This study was undertaken to determine the prevalence of hallucinations and delusions in Parkinson's disease, to describe such symptoms phenomenologically, and possibly to determine factors associated with their development. In addition, the role of the visual system in relation to visual hallucinations was examined.
102 consecutive patients diagnosed with strictly defined Parkinson's disease were examined for the presence of hallucinations and delusions and assessed for visual acuity, cognition, depression using the geriatric depression scale, disease severity as measured by the UPDRS, and other clinical variables.
Of 102 consecutive patients, 29.4% (n=30) had hallucinations or delusions, four (3.9%) were determined to be psychotic due solely to delirium and were excluded from further analysis. Of the 98 remaining patients, 26.5% (n=26) had visual hallucinations. Among these, one patient also had delusions, two had auditory hallucinations, and one had gustatory hallucinations. Visual hallucinations were significantly associated with worse visual acuity, lower cognitive score, higher depression score, and worse disease severity. Hallucinations were not associated with history of psychiatric disease, dose or duration of levodopa or other antiparkinsonian medication treatment, or duration of illness.
Visual hallucinations are common symptoms in Parkinson's disease and are most likely of multifactorial origin. Although higher doses of levodopa are known to be related clinically to hallucinations in individual patients, the results suggest that several underlying characteristics of patients with Parkinson's disease (disease severity, dementia, depression, worse visual acuity) may be more important determinants of which patients experience hallucinations. The data also provide preliminary evidence that abnormality of the visual system may be related to visual hallucinations in Parkinson's disease, as has been found in other disorders with visual hallucinations.
本研究旨在确定帕金森病中幻觉和妄想的患病率,从现象学角度描述此类症状,并可能确定与其发生相关的因素。此外,还研究了视觉系统与视幻觉的关系。
对102例被诊断为严格定义的帕金森病的连续患者进行检查,以确定是否存在幻觉和妄想,并使用老年抑郁量表评估视力、认知、抑郁情况,用统一帕金森病评定量表(UPDRS)测量疾病严重程度以及其他临床变量。
在102例连续患者中,29.4%(n = 30)有幻觉或妄想,4例(3.9%)仅因谵妄被判定为精神病性状态,被排除在进一步分析之外。在其余98例患者中,26.5%(n = 26)有视幻觉。其中,1例患者也有妄想,2例有幻听,1例有幻味。视幻觉与较差的视力、较低的认知评分、较高的抑郁评分和更严重的疾病严重程度显著相关。幻觉与精神病史、左旋多巴或其他抗帕金森药物治疗的剂量或疗程、病程无关。
视幻觉是帕金森病的常见症状,很可能是多因素起源。虽然已知较高剂量的左旋多巴在临床上与个别患者的幻觉有关,但结果表明,帕金森病患者的几个潜在特征(疾病严重程度、痴呆、抑郁、较差的视力)可能是哪些患者会出现幻觉的更重要决定因素。数据还提供了初步证据,表明视觉系统异常可能与帕金森病中的视幻觉有关,正如在其他有视幻觉疾病中所发现的那样。